Abstract
Mitral regurgitation (MR) is a type of heart valve disease, which is characterized by systolic blood flow reversal from the left ventricle to the left atrium. In Taiwan, little data is available in describing the clinical characteristics, treatment patterns, and economic burden in patients with sMR. We aim to quantify the impact of sMR on Taiwan’s healthcare system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
